LTC providers ‘win’ with new regs on drug repackaging, group says
Published by McKnight’s
Guidance on medication repackaging recently published by the U.S. Food and Drug Administration is earning praise from one long-term care pharmacy group, which says the final guidelines help reduce drug-related risks for residents.
The final guidance, published Thursday, included the elimination of a proposed 14-day limit on pre-packaging medications that could have put residents at risk and added significant compliance costs for long-term care pharmacies, the Senior Care Pharmacy Coalition said. Long-term care pharmacies can repackage medications under the final guidance, as long as the drugs do not leave the pharmacy without a patient-specific prescription or chart order.
The FDA’s guidelines also permit long-term care pharmacies to continue to use remote dispensing technology, and supply non-sterile products to facilities in emergency kits.
“The Agency heard our concerns about the unintended consequences of its original draft and agreed to exercise enforcement discretion to permit needed medication packaging and emergency kit practices to continue,” said Alan G. Rosenbloom, president and CEO of SCPC.
Rosenbloom added that the FDA’s guidance “represents a strong start for the LTC pharmacy sector in 2017, and more broadly recognizes LTC pharmacies’ unique value in the U.S. health care continuum.”
Click here to see the original article on the McKnight’s website.
Recent Posts
-
Senior Care Pharmacy Coalition Opposes CMS Final Rule on Minimum Staffing Standards for LTC Facilities
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy sector, released a statement today regarding its opposition to the Centers for Medicare & Medicaid Services (CMS) final rule on minimum staffing standards for long-term care (LTC) facilities.
-
Senior Care Pharmacy Coalition Shares Comments with CMS Regarding Medicare Part D Restructuring Guidance: “Smoothing Provisions”
SCPC filed comments with CMS in response to their guidance on the implementation of the Medicare Part D restructuring portion of the Inflation Reduction Act (IRA).
-
Drug pricing efforts threaten ‘very existence’ of LTC pharmacies: reps
President Biden in his State of the Union address last week vowed to end “Big Pharma’s” grip on prescription drug pricing and cut costs for seniors and taxpayers by another $200 million.
But the president’s plans to expand his administration’s first-ever Medicare drug price negotiations could spell big trouble for the pharmacists who support seniors living in long-term care settings, advocates warned in response.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.